Malik and Malik Pharma Private Limited
About Malik and Malik Pharma Private Limited
Data last updated:
Malik and Malik Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2000PTC228159. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.32 Lakh. It is led by directors Balveer Singh and Rohit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 36 Ground Floor Shop No. 5, Paradise Shopping Plaza Madhu Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹67,240, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹17,140 (net margin -25.5%) and EBITDA of -₹17,140 (EBITDA margin -25.5%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Malik and Malik Pharma Private Limited
Malik and Malik Pharma has one previous CIN (Corporate Identification Number): U51397HP2000PTC023246. The current CIN is U51397DL2000PTC228159, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397DL2000PTC228159 | Current |
| U51397HP2000PTC023246 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 36 Ground Floor Shop No. 5, Paradise Shopping Plaza Madhu Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Malik and Malik Pharma Private Limited
The main business activity of Malik and Malik Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Malik and Malik Pharma Private Limited FY 2025 filings available
Malik and Malik Pharma Private Limited reported revenue of ₹67,240 (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Malik and Malik Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 10% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Malik and Malik Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹17,140 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹17,140 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Malik and Malik Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -25.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Malik and Malik Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Malik and Malik Pharma Private Limited
Malik and Malik Pharma has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balveer Singh Also directs: Anamya Reality Private Limited, Anamya Buildwell Private Limited, Anantah Buildcon Private Limited and 2 more | Additional Director | 26 Aug 2016 | 10 Years 1 Months | Current |
| Rohit Kumar Also directs: Anamya Reality Private Limited, Anamya Buildwell Private Limited, Anantah Buildcon Private Limited and 2 more | Additional Director | 26 Aug 2016 | 10 Years 1 Months | Current |
Peer Comparison of Malik and Malik Pharma Private Limited
Malik and Malik Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Camerin Drugs and Pharmaceuticals Ltd | ₹69,127 (FY 2019) | •••• | •••• | -83.0% | •••• | Cannanore, Kerala, India |
| Shatdal Pharma Private Limited | ₹68,525 (FY 2025) | •••• | •••• | -69.0% | •••• | Nagpur, Maharashtra, India |
| Alexin Healthcare Private Limited | ₹67,500 (FY 2025) | •••• | •••• | -99.0% | •••• | Mumbai, Maharashtra, India |
| Heartbit Pharma Private Limited | ₹67,484 (FY 2016) | •••• | •••• | 100.0% | •••• | Ahmedabad, Gujarat, India |
| Oboi Laboratories Pvt Ltd | ₹67,430 (FY 2024) | •••• | •••• | 180.0% | •••• | Mumbai, Maharashtra, India |
| Malik and Malik Pharma Private Limited this company | ₹67,240 (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Toshi Biopharm Private Limited | ₹67,134 (FY 2025) | •••• | •••• | -99.0% | •••• | Delhi, India |
| Maze Medicare Private Limited | ₹66,925 (FY 2025) | •••• | •••• | •••• | Rohtak, Haryana, India | |
| Siddhaquest Pharmaceuticals Private Limited | ₹66,682 (FY 2021) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Abhinav Drug Chem Private Limited | ₹66,532 (FY 2025) | •••• | •••• | 11.0% | •••• | Gujarat, India |
| Avaomme Medicare Private Limited | ₹65,000 (FY 2024) | •••• | •••• | 242.0% | •••• | Kannauj, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Malik and Malik Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Malik and Malik Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Malik and Malik Pharma Private Limited
Malik and Malik Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Malik and Malik Pharma Private Limited
Malik and Malik Pharma Private Limited has 1 court case on record: 1 filed by Malik and Malik Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, CHANDIGARH (UT) | Company petition | Filed by the company against Registrar of Companies, PB., CHD. & HP. | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Malik and Malik Pharma Private Limited
Employment history and EPFO contributions of people linked to Malik and Malik Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Malik and Malik Pharma Private Limited
Malik and Malik Pharma Private Limited has 12 board changes on record since 2009: 2 appointments and 10 cessations. The latest: Hardeep Singh ceased to be Additional Director on 29 Aug 2016.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Malik and Malik Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Malik and Malik Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Malik and Malik Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Malik and Malik Pharma Private Limited
Malik and Malik Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Malik and Malik Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Malik and Malik Pharma Private Limited
Malik and Malik Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2000 (26+ years old) and is registered under CIN U51397DL2000PTC228159.
Malik and Malik Pharma reported revenue of ₹67,240 for FY 2025 (up 10% YoY).
Malik and Malik Pharma has 2 current directors:
- Balveer Singh - Additional Director
- Rohit Kumar - Additional Director
Malik and Malik Pharma reported a net loss of ₹17,140 (net margin -25.5%) and EBITDA of -₹17,140 (EBITDA margin -25.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Malik and Malik Pharma is 44% over three years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
No. Malik and Malik Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Malik and Malik Pharma is U51397DL2000PTC228159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malik and Malik Pharma has 1 court case on record: 1 filed by the company.
Malik and Malik Pharma was incorporated on 10 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Malik and Malik Pharma by revenue are Camerin Drugs and Pharmaceuticals Ltd, Shatdal Pharma Private Limited, Alexin Healthcare Private Limited, Heartbit Pharma Private Limited, Oboi Laboratories Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Hardeep Singh ceased to be Additional Director on 29 Aug 2016. Mam Raj ceased to be Additional Director on 29 Aug 2016. Balveer Singh was appointed as Additional Director on 26 Aug 2016. Malik and Malik Pharma has 12 board changes on record in total.